Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Inventory (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Inventory for 13 consecutive years, with $20.4 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 122.19% to $20.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.4 million through Dec 2025, up 122.19% year-over-year, with the annual reading at $20.4 million for FY2025, 122.19% up from the prior year.
  • Inventory for Q4 2025 was $20.4 million at Niagen Bioscience, up from $18.8 million in the prior quarter.
  • The five-year high for Inventory was $20.4 million in Q4 2025, with the low at $9.2 million in Q4 2024.
  • Average Inventory over 5 years is $13.7 million, with a median of $12.7 million recorded in 2021.
  • The sharpest move saw Inventory crashed 36.72% in 2024, then skyrocketed 122.19% in 2025.
  • Over 5 years, Inventory stood at $13.6 million in 2021, then increased by 7.91% to $14.7 million in 2022, then dropped by 1.04% to $14.5 million in 2023, then plummeted by 36.72% to $9.2 million in 2024, then skyrocketed by 122.19% to $20.4 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $20.4 million, $18.8 million, and $14.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.